Published in J Cancer Res Clin Oncol on January 19, 2005
Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin Exp Metastasis (2008) 0.85
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.80
Mouse models of colorectal cancer. Chin J Cancer (2011) 0.78
In vitro study on the schedule-dependency of the interaction between pemetrexed, gemcitabine and irradiation in non-small cell lung cancer and head and neck cancer cells. BMC Cancer (2010) 0.78
Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases. PLoS One (2016) 0.75
Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma. Front Oncol (2017) 0.75
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet (2002) 12.16
The blood supply of neoplasms in the liver. Am J Pathol (1955) 4.34
Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases. Am J Surg (1990) 2.12
Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology (2003) 1.82
Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer (2002) 1.65
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol (2003) 1.63
A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol (2001) 1.61
Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg (1999) 1.59
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent. Clin Cancer Res (2004) 1.48
Treatment of colorectal liver metastases. Br J Surg (1999) 1.41
Current treatment for liver metastases from colorectal cancer. World J Gastroenterol (2003) 1.28
Vascularization of small liver metastases. Br J Surg (1989) 1.27
Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol (2003) 1.24
The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery (1974) 1.22
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer (1998) 1.14
Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Cancer Res (1999) 1.12
Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts. Clin Cancer Res (2000) 1.05
The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis (2000) 0.97
Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis (1993) 0.92
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J Clin Oncol (2000) 0.89
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum (1997) 0.89
BLOOD SUPPLY TO HEPATIC V2 CARCINOMA IMPLANTS AS MEASURED BY RADIOACTIVE MICROSPHERES. Proc Soc Exp Biol Med (1965) 0.88
Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model. Clin Exp Metastasis (1999) 0.87
Colorectal metastases to the liver: selective chemoembolization. Radiology (1993) 0.86
The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma. Clin Exp Metastasis (2000) 0.86
New technique for superselective arterial (chemo-) embolization of the rat liver. Lab Anim Sci (1999) 0.83
Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepatogastroenterology (2001) 0.83
Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer (1991) 0.81
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Clin Cancer Res (2004) 0.80
Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol (2000) 0.80
Pemetrexed in the treatment of selected solid tumors. Semin Oncol (2002) 0.80
In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines. Clin Cancer Res (2002) 0.79
Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. J Cancer Res Clin Oncol (1986) 0.78
Superiority of combined chemo-embolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats. J Cancer Res Clin Oncol (2003) 0.76
Effect of starch microspheres on the passage of labelled erythrocytes and a low molecular weight marker through the liver. Acta Oncol (1987) 0.76
Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction. J Cancer Res Clin Oncol (2004) 0.76
Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. Oncol Rep (2004) 0.76
Gemcitabine and pemetrexed disodium combinations in vitro and in vivo. Lung Cancer (2001) 0.76
Regional chemotherapy for colorectal hepatic metastases using degradable starch microspheres. A review. Acta Oncol (1991) 0.75
Hepatic tumor spread of colorectal cancer in a laparoscopic animal model. Surg Endosc (2000) 0.75
Pemetrexed for treatment of advanced non-small cell lung cancer. Semin Oncol (2004) 0.75
[Colorectal cancers: management of metastatic cancers]. Rev Prat (2004) 0.75
Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res (2005) 2.05
Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene (2005) 1.41
Osteonectin influences growth and invasion of pancreatic cancer cells. Ann Surg (2005) 1.38
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. Int J Cancer (2011) 1.07
PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy. Oncol Rep (2008) 1.04
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer. Gut (2007) 1.03
Delivery and expression of pDNA embedded in collagen matrices. J Control Release (2004) 1.03
Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease. Oncol Rep (2006) 1.02
Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther (2004) 1.00
Quantitative analysis of conditional gene inactivation using rationally designed, tetracycline-controlled miRNAs. Nucleic Acids Res (2010) 0.98
Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines. Cancer Biol Ther (2010) 0.95
Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology (2005) 0.95
Cilengitide inhibits metastatic bone colonization in a nude rat model. Oncol Rep (2011) 0.95
Assessment of pancreatic hardness-surgeon versus durometer. J Surg Res (2010) 0.95
Indications and early outcomes for total pancreatectomy at a high-volume pancreas center. HPB Surg (2010) 0.94
Characterization of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer (2005) 0.92
The insulin-like growth factor binding proteins 3 and 7 are associated with colorectal cancer and liver metastasis. Cancer Biol Ther (2011) 0.92
Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma. Cancer Lett (2011) 0.92
Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana. FASEB J (2006) 0.90
Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI. Neoplasia (2008) 0.90
Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells. Int J Oncol (2004) 0.90
Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients. Clin Cancer Res (2004) 0.90
Intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol (2008) 0.90
Endovascular treatment and complete regression of an infected abdominal aortic aneurysm. J Endovasc Ther (2002) 0.90
Bacteribilia after preoperative bile duct stenting: a prospective study. J Clin Gastroenterol (2009) 0.89
Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft--no benefit of combination therapy. Int J Colorectal Dis (2012) 0.88
Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma--a rationale for a molecular targeting strategy? World J Gastroenterol (2007) 0.88
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective. J Cancer Res Clin Oncol (2013) 0.86
Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin Exp Metastasis (2008) 0.85
Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit. J Gastrointest Surg (2009) 0.85
TME quality in rectal cancer surgery. Eur J Med Res (2010) 0.85
Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine. Toxicol Appl Pharmacol (2005) 0.84
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity. Cancer Chemother Pharmacol (2010) 0.84
The difficult hepaticojejunostomy after pancreatic head resection: reconstruction with a T tube. Am J Surg (2013) 0.84
Evaluation of riproximin binding properties reveals a novel mechanism for cellular targeting. J Biol Chem (2012) 0.83
K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer. Int J Colorectal Dis (2009) 0.83
Prognostic value of tumor progression-related gene expression in colorectal cancer patients. J Cancer Res Clin Oncol (2012) 0.83
Treatment of bone metastasis induced by MDA-MB-231 breast cancer cells with an antibody against bone sialoprotein. Int J Oncol (2006) 0.83
Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis. Int J Cancer (2010) 0.83
Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis. Cancer Lett (2006) 0.83
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease. J Oncol (2008) 0.82
Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use? Int J Colorectal Dis (2004) 0.82
K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Int J Oncol (2004) 0.81
Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells. Cancer Lett (2002) 0.81
Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. Int J Colorectal Dis (2010) 0.81
Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Int J Colorectal Dis (2003) 0.80
Electrodelivery of drugs into cancer cells in the presence of poloxamer 188. J Biomed Biotechnol (2010) 0.80
Purification and characterization of riproximin from Ximenia americana fruit kernels. Protein Expr Purif (2011) 0.79
The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues. Int J Oncol (2006) 0.79
Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications. Int J Oncol (2003) 0.79
Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions. Clin Exp Metastasis (2012) 0.79
Few genes are associated with the capability of pancreatic ductal adenocarcinoma cells to grow in the liver of nude rats. Oncol Rep (2012) 0.79
Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis. J Cell Mol Med (2012) 0.79
Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients. Oncol Rep (2008) 0.79
Effect of zoledronic acid and an antibody against bone sialoprotein II on MDA-MB-231(GFP) breast cancer cells in vitro and on osteolytic lesions induced in vivo by this cell line in nude rats. Clin Exp Metastasis (2007) 0.78
Treatment of acute delayed visceral hemorrhage after pancreatic surgery from hepatic arteries with covered stents. J Gastrointest Surg (2011) 0.78
CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells. Med Oncol (2015) 0.78
Tailored resective pancreatic surgery for pediatric patients with chronic pancreatitis. J Pediatr Surg (2008) 0.77
Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients. Int J Cancer (2003) 0.77
The expression level of the tumor suppressor retinoblastoma protein (Rb) influences the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium (ErPC3). Cancer Biol Ther (2007) 0.77
Antineoplastic and anticlastogenic properties of curcumin. Ann N Y Acad Sci (2007) 0.77
Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound. J Vis Exp (2012) 0.77
Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer. J Cancer Res Clin Oncol (2011) 0.77
Erucylphospho-N,N,N-trimethylpropylammonium shows substantial cytotoxicity in multiple myeloma cells. Ann N Y Acad Sci (2009) 0.77
Superiority of combined chemo-embolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats. J Cancer Res Clin Oncol (2003) 0.76
Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction. J Cancer Res Clin Oncol (2004) 0.76
Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. Oncol Rep (2004) 0.76
Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells. Int J Oncol (2010) 0.76
Interleukin-6, osteopontin and Raf/MEK/ERK signaling modulate the sensitivity of human myeloma cells to alkylphosphocholines. Leuk Res (2012) 0.76
Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins. J Cancer Res Clin Oncol (2012) 0.76
Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays. Oncol Rep (2011) 0.75
Biodistribution of antisense nanoparticles in mammary carcinoma rat model. Drug Deliv (2010) 0.75
Cytotoxic activity of platinum(II) and palladium(II) complexes of N-3-pyridinylmethanesulfonamide: the influence of electroporation. Z Naturforsch C (2009) 0.75
A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia--a possible new therapeutic target. Hematology (2012) 0.75
Does expression of receptor tyrosine kinases in gastric adenocarcinoma correlate with clinicopathological parameters? Hepatogastroenterology (2010) 0.75
Combination with an antisense oligonucleotide synergistically improves the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium in chronic myeloid leukemia cell lines. Mol Cancer Ther (2002) 0.75
Metastasis-related processes show various degrees of activation in different stages of pancreatic cancer rat liver metastasis. Oncol Res Treat (2014) 0.75